Overall, these data demonstrate that the ESGS‐related prognostic model could be used to independently predict OS in CRC patients, further supporting the oncogenic role of the ELK4‐SP1/3 transcriptional complex in CRC. This evidence concerns the gene ELK4 and colorectal carcinoma.